JPET Celsis microsomes equal better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on June 10, 2004; DOI: 10.1124/jpet.104.069674


0022-3565/04/3112-794-802$20.00
JPET 311:794-802, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.069674v1
311/2/794    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Desai, A. N.
Right arrow Articles by Eikenburg, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Desai, A. N.
Right arrow Articles by Eikenburg, D. C.

CELLULAR AND MOLECULAR

Simultaneous {alpha}2B- and {beta}2-Adrenoceptor Activation Sensitizes the {alpha}2B-Adrenoceptor for Agonist-Induced Down-Regulation

Aarti N. Desai, Kelly M. Standifer, and Douglas C. Eikenburg

Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas

We recently reported that {alpha}2A-adrenoceptor (AR) desensitization and down-regulation occurs after 24-h treatment with epinephrine (EPI) (0.3 µM) in BE(2)-C cells that express both {alpha}2- and {beta}2-ARs. The same concentration of norepinephrine (NE) has no effect. The effect of EPI is prevented by {beta}2-AR blockade and is associated with an increase in G protein-coupled receptor kinase 3 (GRK3) expression. Because differences in agonist-induced down-regulation of the {alpha}2A-versus {alpha}2B-ARs have been reported, the present study examines the effects of simultaneous activation of {alpha}2B- and {beta}2-ARs on {alpha}2B-AR number and signaling. We studied NG108 cells that naturally express {alpha}2B-ARs, and BN17 cells, NG108 cells transfected to express the human {beta}2-AR. In NG108 cells, {alpha}2B-AR desensitization and down-regulation require treatment with 20 µM EPI or NE; GRK expression was not changed. In BN17 cells expressing {beta}2-ARs, the threshold EPI concentration for {alpha}2B-AR desensitization and down-regulation was reduced to 0.3 µM; 10 µM NE was required for the same effect. Furthermore, 24-h EPI or NE treatments that produced desensitization also resulted in a selective 2-fold up-regulation of GRK3; GRK2 was unchanged. The {beta}-AR antagonist alprenolol (1 µM) and GRK3 antisense (but not sense) DNA blocked 0.3 µM EPI- and 10 µM NE-induced desensitization and down-regulation of the {alpha}2B-AR as well as GRK3 up-regulation. In conclusion, simultaneous activation of {alpha}2B- and {beta}2-ARs results in a 67-fold decrease in the threshold concentration of EPI required for {alpha}2B-AR down-regulation. This lower threshold for down-regulation is associated with {alpha}2B- and {beta}2-AR dependent up-regulation of GRK3 expression.


Received April 15, 2004; accepted June 10, 2004.

Address correspondence to: Dr. Douglas C. Eikenburg, Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX 77204-5037. E-mail: deikenburg{at}uh.edu




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
S. Salim, K. M. Standifer, and D. C. Eikenburg
Extracellular Signal-Regulated Kinase 1/2-Mediated Transcriptional Regulation of G-Protein-Coupled Receptor Kinase 3 Expression in Neuronal Cells
J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 51 - 59.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Salim and D. C. Eikenburg
Role of 90-kDa Heat Shock Protein (Hsp 90) and Protein Degradation in Regulating Neuronal Levels of G Protein-Coupled Receptor Kinase 3
J. Pharmacol. Exp. Ther., March 1, 2007; 320(3): 1106 - 1112.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. N. Desai, S. Salim, K. M. Standifer, and D. C. Eikenburg
Involvement of G Protein-Coupled Receptor Kinase (GRK) 3 and GRK2 in Down-Regulation of the {alpha}2B-Adrenoceptor
J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1027 - 1035.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. N. Desai, K. M. Standifer, and D. C. Eikenburg
Cellular G Protein-Coupled Receptor Kinase Levels Regulate Sensitivity of the {alpha}2B-Adrenergic Receptor to Undergo Agonist-Induced Down-Regulation
J. Pharmacol. Exp. Ther., February 1, 2005; 312(2): 767 - 773.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.